Israelis find biomarker for possible relapse-free lung cancer treatment
Israeli researchers have identified a biomarker that might revolutionize lung cancer treatment.
A Weizmann Institute of Science study’s findings introduce a new avenue for personalized medicine that could lead to relapse-free treatment for certain lung cancer patients.
Read more: Jewish News Syndicate
